Chemical.AI Raises ￥30M in Series A Funding Round

(VCBeat) Mar. 5, 2021 -- Wuhan Zhihua Technology Co., Ltd. ("Chemical.AI") recently announced the completion of a Series A financing of more than 30 million RMB, led by Sequoia Capital China Seed Fund, with participation from Nest.Bio Ventures and the existing investor FREES FUND. Proceeds from the transaction will be mainly used for market expansion, exploration of new directions and recruitment of senior R&D talents. Previously, Chemical.AI has completed the angel round of financing in 2019.

Chemical.AI is a technology company driven by big data and AI, committed to using AI and big data in chemistry to solve the pre-clinical chemical synthesis problems of new drug R&D, in order to improve the efficiency of R&D for pharmaceutical companies. The founding team of Chemical.AI has been working in the field of chemical informatics for more than ten years and has rich experience in R&D. The company has accumulated a large number of professional data in chemical engineering. It is the pioneer in the field of chemical synthesis of new drugs based on AI in China.

Dr. Xia Ning, the founder of Chemical.AI, said that Chemical.AI's strategy is to develop the software in advance. At present, the company has completed the construction of the algorithm platform based on its core technology, and has reached cooperation with four leading enterprises at home and abroad, to help them accelerate the chemical synthesis speed. At the same time, Chemical.AI will also explore the development of hardware in the future, to verify the synthetic analysis tools and realize the organic combination of hardware and software.

Sequoia Capital China, as the "entrepreneur behind entrepreneur", focuses on investment in four directions including technology/media, healthcare, consumer goods/modern services and industrial technology. Over the past 15 years, Sequoia Capital China has invested in nearly 600 enterprises with distinctive technical characteristics, innovative business models, and high growth and development potential.

Nest.Bio Ventures is a venture creation and venture capital firm focused on developing, funding, and commercializing life science companies globally. They believe in hands-on investment philosophy and roll up their sleeves alongside founders to translate high-impact science into sustainable clinical therapies.